BCAP29
(B-Cell Receptor-Associated Protein 29 (BCAP29))
Protein Region
Middle Region
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-BCAP29 antibody (Catalog #: ARP44557_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BCAP29
(B-Cell Receptor-Associated Protein 29 (BCAP29))
Synonyme
AW208404 Peptide, Bap29 Peptide, BAP29 Peptide, B-cell receptor associated protein 29 Peptide, B cell receptor associated protein 29 Peptide, B-cell receptor-associated protein 29 Peptide, BCAP29 Peptide, Bcap29 Peptide
Hintergrund
BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.